Peregrine Pharma (PPHM) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.82 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Super Micro Computer (SMCI) Falls 6%
- Acme United (ACU) Misses Q1 EPS by 20c
- Super Micro Computer (SMCI) now down nearly 20%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
